The University of Southampton
University of Southampton Institutional Repository

25. Immunotherapy of allergic disease

25. Immunotherapy of allergic disease
25. Immunotherapy of allergic disease
Specific immunotherapy involves the administration of allergen extracts to achieve clinical tolerance of the allergens which cause symptoms in patients with allergic conditions. Immunotherapy has been shown to be effective in patients with mild forms of allergic disease, and also in those who do not respond well to standard drug therapy.
Recent studies suggest that specific immunotherapy may also modify the course of allergic disease, by reducing the risk of developing new allergic sensitizations, and also inhibiting the development of clinical asthma in children treated for allergic rhinitis. Specific immunotherapy remains the treatment of choice for patients with systemic allergic reactions to wasp and bee stings.
The precise mechanisms responsible for the beneficial effects of SIT remain a matter of research and debate. An effect on regulatory T cells seems most probable, associated with switching of allergen-specific B cells towards IgG4 production. Few direct comparisons of specific immunotherapy and drug therapy have been made. Existing data suggest that the effects of specific immunotherapy take longer to come on, but once established, specific immunotherapy will give long-lasting relief of allergic symptoms, whereas the benefits of drugs only last as long as they are continued. (J Allergy Clin Immunol 2003;111:S712-9.)
immunotherapy, immunomodulation, rhinitis, asthma, t cell, b cell, igg, igc
0091-6749
S712-S719
Frew, Anthony J.
4887b766-67c6-4d69-940d-4c06c0890b76
Frew, Anthony J.
4887b766-67c6-4d69-940d-4c06c0890b76

Frew, Anthony J. (2003) 25. Immunotherapy of allergic disease. Journal of Allergy and Clinical Immunology, 111 (2 Suppl), S712-S719. (doi:10.1067/mai.2003.84).

Record type: Article

Abstract

Specific immunotherapy involves the administration of allergen extracts to achieve clinical tolerance of the allergens which cause symptoms in patients with allergic conditions. Immunotherapy has been shown to be effective in patients with mild forms of allergic disease, and also in those who do not respond well to standard drug therapy.
Recent studies suggest that specific immunotherapy may also modify the course of allergic disease, by reducing the risk of developing new allergic sensitizations, and also inhibiting the development of clinical asthma in children treated for allergic rhinitis. Specific immunotherapy remains the treatment of choice for patients with systemic allergic reactions to wasp and bee stings.
The precise mechanisms responsible for the beneficial effects of SIT remain a matter of research and debate. An effect on regulatory T cells seems most probable, associated with switching of allergen-specific B cells towards IgG4 production. Few direct comparisons of specific immunotherapy and drug therapy have been made. Existing data suggest that the effects of specific immunotherapy take longer to come on, but once established, specific immunotherapy will give long-lasting relief of allergic symptoms, whereas the benefits of drugs only last as long as they are continued. (J Allergy Clin Immunol 2003;111:S712-9.)

This record has no associated files available for download.

More information

Published date: 2003
Keywords: immunotherapy, immunomodulation, rhinitis, asthma, t cell, b cell, igg, igc

Identifiers

Local EPrints ID: 27054
URI: http://eprints.soton.ac.uk/id/eprint/27054
ISSN: 0091-6749
PURE UUID: ec072de9-5b68-4615-a4f5-7cc1beb5c121

Catalogue record

Date deposited: 26 Apr 2006
Last modified: 15 Mar 2024 07:15

Export record

Altmetrics

Contributors

Author: Anthony J. Frew

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×